NCT01959022View on ClinicalTrials.gov

A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Stress Disorders, Post-Traumatic
Interventions
DRUG

Doxazosin XL

Subjects will participate in a 2 week flexible-dose titration of doxazosin based on clinical response and adverse effects followed by 6 weeks of steady dose treatment.

Trial Locations (1)

94121

San Francisco Veterans Affairs Medical Center, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Northern California Institute of Research and Education

OTHER

lead

San Francisco Veterans Affairs Medical Center

FED

NCT01959022 - A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD | Biotech Hunter | Biotech Hunter